News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,693 Results
Type
Article (59750)
Company Profile (144)
Press Release (607799)
Multimedia
Podcasts (65)
Webinars (14)
Section
Business (181048)
Career Advice (2853)
Deals (33549)
Drug Delivery (119)
Drug Development (77887)
Employer Resources (186)
FDA (15211)
Job Trends (14647)
News (315375)
Policy (30136)
Tag
Academia (2791)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (89)
Alliances (45820)
ALS (91)
Alzheimer's disease (1355)
Antibody-drug conjugate (ADC) (125)
Approvals (15220)
Artificial intelligence (282)
Autoimmune disease (23)
Automation (16)
Bankruptcy (306)
Best Places to Work (11403)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (91)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (277)
Cancer (2240)
Cardiovascular disease (169)
Career advice (2416)
Career pathing (34)
CAR-T (164)
Cell therapy (444)
Cervical cancer (21)
Clinical research (63199)
Collaboration (834)
Compensation (360)
Complete response letters (24)
COVID-19 (2613)
CRISPR (44)
C-suite (260)
Cystic fibrosis (102)
Data (2157)
Decentralized trials (2)
Denatured (27)
Depression (47)
Diabetes (255)
Diagnostics (6436)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (107)
Drug shortages (24)
Duchenne muscular dystrophy (89)
Earnings (63678)
Editorial (40)
Employer branding (25)
Employer resources (160)
Events (101379)
Executive appointments (764)
FDA (16471)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (110)
Generative AI (25)
Gene therapy (305)
GLP-1 (705)
Government (4620)
Grass and pollen (6)
Guidances (56)
Healthcare (18609)
Huntington's disease (21)
IgA nephropathy (24)
Immunology and inflammation (115)
Indications (28)
Infectious disease (2754)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (98)
Interviews (536)
IPO (15335)
IRA (43)
Job creations (3641)
Job search strategy (2031)
Kidney cancer (10)
Labor market (36)
Layoffs (516)
Leadership (23)
Legal (6716)
Liver cancer (75)
Lung cancer (325)
Lymphoma (146)
Machine learning (7)
Management (62)
Manufacturing (299)
MASH (65)
Medical device (12777)
Medtech (12782)
Mergers & acquisitions (18796)
Metabolic disorders (657)
Multiple sclerosis (80)
NASH (20)
Neurodegenerative disease (86)
Neuropsychiatric disorders (27)
Neuroscience (1889)
NextGen: Class of 2025 (6582)
Non-profit (4500)
Now hiring (40)
Obesity (343)
Opinion (248)
Ovarian cancer (78)
Pain (92)
Pancreatic cancer (78)
Parkinson's disease (142)
Partnered (21)
Patents (239)
Patient recruitment (112)
Peanut (49)
People (60113)
Pharmaceutical (39)
Pharmacy benefit managers (15)
Phase I (19906)
Phase II (27909)
Phase III (20488)
Pipeline (1146)
Policy (138)
Postmarket research (2441)
Preclinical (8509)
Press Release (69)
Prostate cancer (109)
Psychedelics (35)
Radiopharmaceuticals (252)
Rare diseases (370)
Real estate (6209)
Recruiting (74)
Regulatory (20896)
Reports (50)
Research institute (2534)
Resumes & cover letters (429)
Rett syndrome (5)
RNA editing (4)
RSV (40)
Schizophrenia (70)
Series A (136)
Series B (84)
Service/supplier (12)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (151)
Sponsored (30)
Startups (3563)
State (1)
Stomach cancer (12)
Supply chain (62)
Tariffs (28)
The Weekly (36)
Vaccines (696)
Venture capitalists (42)
Weight loss (225)
Women's health (32)
Worklife (20)
Date
Today (168)
Last 7 days (840)
Last 30 days (2568)
Last 365 days (31613)
2025 (10382)
2024 (33652)
2023 (37952)
2022 (48183)
2021 (53232)
2020 (52125)
2019 (46060)
2018 (35037)
2017 (31723)
2016 (31170)
2015 (36555)
2014 (29391)
2013 (25766)
2012 (27265)
2011 (27471)
2010 (26084)
Location
Africa (917)
Alabama (56)
Alaska (7)
Arizona (185)
Arkansas (14)
Asia (39081)
Australia (7015)
California (5711)
Canada (1890)
China (491)
Colorado (255)
Connecticut (264)
Delaware (140)
Europe (90529)
Florida (869)
Georgia (205)
Hawaii (1)
Idaho (56)
Illinois (549)
India (28)
Indiana (299)
Iowa (10)
Japan (155)
Kansas (100)
Kentucky (25)
Louisiana (11)
Maine (61)
Maryland (845)
Massachusetts (4190)
Michigan (238)
Minnesota (355)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (24)
Nevada (59)
New Hampshire (61)
New Jersey (1680)
New Mexico (29)
New York (1691)
North Carolina (982)
North Dakota (9)
Northern California (2490)
Ohio (198)
Oklahoma (15)
Oregon (37)
Pennsylvania (1253)
Puerto Rico (11)
Rhode Island (29)
South America (1237)
South Carolina (18)
South Dakota (1)
Southern California (2145)
Tennessee (96)
Texas (858)
United States (21873)
Utah (175)
Virginia (139)
Washington D.C. (64)
Washington State (531)
West Virginia (3)
Wisconsin (61)
667,693 Results for "weizmann institute of science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of Understanding (MoU).
March 1, 2023
·
5 min read
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
·
6 min read
·
Angela Gabriel
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
April 21, 2025
·
6 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
Press Releases
Frazier Life Sciences Appoints Gordon Empey as Chief Operating Officer
May 1, 2025
·
3 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
BioForest
Allen Institute for Cell Science launches first disease-specific cell line collections
The Allen Institute for Cell Science unveiled a set of tools to accelerate research into hypertrophic cardiomyopathy, the most common genetic heart condition in the world: six new cell line collections, each carrying a different mutation associated with HCM.
June 4, 2024
·
5 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
April 30, 2025
·
3 min read
1 of 66,770
Next
